Previous Article | Next Article ![]()
Journal of Bacteriology, November 2002, p. 6115-6122, Vol. 184, No. 22
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.22.6115-6122.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Isao Fujii,* Shigeharu Harada, Ushio Sankawa,
and Yutaka Ebizuka
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Received 28 May 2002/ Accepted 16 August 2002
|
|
|---|
|
|
|---|
-rhodomycinone, etc. Figure 1 shows the chemical structures of representative anthracycline antibiotics.
![]() View larger version (19K): [in a new window] |
FIG. 1. Chemical structures of anthracycline antibiotics.
|
![]() View larger version (28K): [in a new window] |
FIG. 2. Organization of PKS gene clusters for anthracycline antibiotics. The dau/dps genes are from S. peucetius and Streptomyces sp. strain C5, which produce daunorubicin/doxorubicin, and the sno genes are from S. nogalater, which is a producer of nogalamycin. The akn genes are from S. galilaeus for aklavinone-aclacinomycin biosynthesis.
|
![]() View larger version (16K): [in a new window] |
FIG. 3. Biosynthesis scheme of aklavinone.
|
|
|
|---|
Construction of expression plasmids for aknX. The aknX gene in the 3.4-kb BamHI fragment was originally cloned from chromosomal DNA of S. galilaeus strain 3AR-33 (18). For native AknX expression, plasmid pLM 1 was used in which the T7 gene 10 ribosome binding site and translational leader sequence were designed under the control of the T7 promoter. A sense oligonucleotide primer was designed to introduce an EcoRI site (shown underlined) and codons modified to those preferably used in E. coli (shown in boldface type) as follows: 5'-GCA TGC GAA TTC AGG AGA TAT ACA TAT GAC TGA TCA TGA ACC AGG TAC TGA AGG TGC CGA-3'. An antisense oligonucleotide primer was designed to introduce a HindIII site (shown underlined) at its end as follows: 5'-TCT AGA AAG CTT TCA TAT CTC CTC CCC TTC GGA-3'. The amplified product was subcloned into the pT7Blue T-vector and sequenced to confirm that no unintended mutations had been introduced. The EcoRI-HindIII fragment cleaved from the pT7Blue subclone was reintroduced into EcoRI- and HindIII-digested pLM 1 to construct pLM X-1.
The plasmid pET hisC-X was constructed to express AknX with a His6 tag at its C terminus (AknX His-C). The sense oligonucleotide primer pET-X-F was designed to introduce an NdeI site (shown underlined) and codons modified to those preferably used in E. coli (shown in boldface type) as follows: 5'-GAA TTC CAT ATG ACT GAT CAT GAA CCA GGT ACT GAA GGT GCC GAC GCC GTC ACC-3'. The antisense oligonucleotide primer pET-X-R was designed to replace the stop codon with an XhoI site (shown underlined) as follows: 5'-GCA TGC CTC GAG TCA TAT CTC CTC CCC TTC GGA-3'. The amplified product was subcloned into the pT7Blue T-vector, and the plasmid was named pT7 hisC-X; the insert sequence for this plasmid was confirmed to avoid unintended incorporation of mutations. The NdeI-XhoI fragment of pT7 hisC-X was ligated with NdeI- and XhoI-digested pET22b vector to construct pET hisC-X, which could express AknX His-C.
The plasmid pET hisN-X was also constructed to express AknX with a His6 tag at its N terminus (AknX His-N). A sense oligonucleotide primer was designed to introduce an NdeI site (shown underlined), six consecutive His codons, and codons modified to those preferably used in E. coli (shown in boldface type) as follows: 5'-GAG CAT ATG CAC CAT CAT CAT CAT CAT ACT GAT CAT GAA CCA GGT ACC GAG GGG GCC GAC-3'. An antisense primer was designed to introduce a PstI site (shown underlined) after the termination codon as follows: 5'-GGA CTG CAG TCA TAT CTC CTC CCC TTC GGA-3'. The amplified product was subcloned into pT7Blue T-vector, and the plasmid was named pT7 hisN-X; the insert sequence for this plasmid was confirmed. pT7 hisN-X was digested with PstI and then blunt ended with T4 DNA polymerase. Then, it was further digested with NdeI to obtain an aknX gene fragment with an NdeI end and a blunt end. This fragment was ligated with pET22b which was blunt ended at its EcoRI cleaved site and then digested with NdeI. The resultant plasmid was named pET hisN-X and could express AknX His-N.
Site-directed mutagenesis by PCR. Site-directed mutations of the aknX gene were introduced by PCR. First PCR was performed to amplify the region from the mutation site to the start codon or stop codon. Then, the first PCR product was used as a primer to amplify the full-length mutated aknX gene. The following primers were used as mutation primers for the first PCR (mutated bases are shown in boldface type): R42K antisense primer, 5'-GAC GAA GCC CGG CTG CTT TGC CAT GAA CTC-3'; H49A antisense primer, 5'-GCA GAG CGT GGC CCG GAC GAA GCC CGG CTG-3'; H49Q antisense primer, 5'-GCA GAG CGT CTG CCG GAC GAA GCC CGG CTG-3'; C52S antisense primer, 5'-CCG TTC CGC GTG CCG TGA GAG CGT GTG GCG-3'; W67F sense primer, 5'-AAC GTC GCC GAG TTT CGG GAC CTC GCC TCG-3'; R74K sense primer, 5'-CTC GCG TCG TTC AAG GCG GCC GTC TCG CAC-3'; and H85A sense primer, 5'-GAC TTC CGG CCG GCA GCC GGC GCG CTG CGC-3'
For R42K, H49A, H49Q, and C52S mutations, the first PCR was performed using the pET-X-F primer and antisense mutation primer with the template aknX gene. The amplified product was purified on agarose gel and used as a primer for single-sided amplification with the template aknX gene. After 10 cycles of amplification, the pET-X-F primer and pET-X-R primer were added to amplify the full-length mutated aknX gene by an additional 25 cycles. For W67F, R74K, and H85A mutations, the first PCR was performed using a sense mutation primer and pET-X-R primer with the template aknX gene. The amplified product was purified on agarose gel and used as a primer for single-sided amplification with the template aknX gene. After 10 cycles of amplification, the pET-X-F primer and pET-X-R primer were added to amplify the full-length mutated aknX gene for an additional 25 cycles. The amplified product was subcloned into the pT7Blue T-vector. The sequence of the entire mutant aknX gene was determined to confirm that the intended mutation was introduced correctly. The cloned mutated aknX gene was cleaved with NdeI and XhoI digestion. Then, the aknX fragment was ligated with NdeI- and XhoI-digested pET22b vector to construct the expression plasmid for mutant AknX.
Overxpression of recombinant AknX. For expression of AknX and its mutant proteins, expression plasmids were introduced into E. coli BL21(DE3)pLysE. Overnight preculture was inoculated in 10 volumes of Luria-Bertani medium and incubated at 37°C for 2 h (to an optical density at 600 nm of 0.4 to 1). Protein expression was induced by the addition of 1 mM isopropyl-ß-D-thiogalactoside (IPTG). After further incubation for 3 h at 37°C, the cells were harvested by centrifugation at 3,200 x g for 5 min. The precipitated cells were stored at -20°C.
Purification of recombinant AknX. All steps were performed on ice or at 4°C. In a typical purification procedure, 26.5 g of cells was suspended in 79.5 ml of lysis buffer (50 mM sodium phosphate buffer, pH 7.8, containing 0.5 M NaCl). After addition of 0.133 mM phenylmethylsulfonyl fluoride and 21.2 mg of lysozyme, the cell suspension was stored at 4°C for 20 min. Then, 106 mg of sodium deoxycholate was added, and the mixture was incubated at 4°C for 20 min and then at 37°C for 5 min. Following DNase I digestion (70 U/g of cell) at room temperature for 20 min, the cell lysate was passed through a 0.2-µm-pore-size membrane filter to obtain a crude cell extract. For the purification of AknX with a His6 tag, crude extract was applied to a Probond Ni2+ affinity column (Invitrogen), and AknX with the His6 tag was eluted with 200 to 500 mM imidazole. AknX fractions collected were passed through a PD-10 column (Pharmacia) equilibrated with 25 mM Tris-HCl buffer, pH 7.5, for buffer exchange. The AknX fraction was divided into 10 subfractions, and each was applied to a Mono Q HR 5/5 anion-exchange column (Pharmacia) for further purification. AknX protein was eluted with a linear NaCl gradient of 0.15 to 0.5 M in 25 mM Tris-HCl buffer, pH 7.5. About 40 mg of purified AknX protein with the His6 tag was obtained by this two-step purification procedure.
Protein analysis.
Protein concentrations were determined spectrophotometrically by the method of Bradford (1), and bovine serum albumin was used as the standard protein. The concentration of the purified protein was determined by absorption at 280 nm. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out using the buffer system of Laemmli (10) in 15% polyacrylamide gel, and protein bands were visualized by staining with Coomassie brilliant blue R-250. The exact molecular masses of purified proteins were determined using a time of flight mass spectrometer (TOF-MS) (KOMPACT MALDI IV; Shimadzu-Kratos). The matrix used was
-cyano-4-hydroxycinnamic acid dissolved in a 1:1 mixture of 0.1% trifluoroacetic acid and ethanol.
Assay of anthrone oxygenase activity.
Anthrone oxygenase activity was measured spectrophotometrically by following the increase of absorbance at 490 nm resulting from the formation of emodin from emodinanthrone at 30°C (3). The reaction mixture consisted of 1.8 ml of 0.5 M potassium phosphate buffer, pH 6.5, and 1 ml of ethylene glycol monomethyl ether containing 0.2 µmol of emodinanthrone. The reaction was started by adding enzyme solution. The reaction rate was calculated using the molecular extinction coefficient difference at 490 nm between emodinanthrone and emodin (
= 6.35 x 103).
Nucleotide sequence accession number. The nucleotide sequence of the aklavinone-aclacinomycin biosynthetic gene cluster of S. galilaeus including aknX has been submitted to the DDBJ/GenBank/EMBL database under the accession no. AB008466.
|
|
|---|
![]() View larger version (97K): [in a new window] |
FIG. 4. SDS-PAGE analysis of the AknX expression in E. coli transformants. After electrophoresis, the gel (15% acrylamide) was stained with Coomassie brilliant blue. Lane 1, protein size marker; lane 2, pET-22b; lane 3, pET hisX; lane 4, pLM 1; lane 5, pLM X-1.
|
![]() View larger version (16K): [in a new window] |
FIG. 5. Reaction schemes of emodinanthrone to emodin (A), aklanonic acid anthrone to aklanonic acid (B), and tetracenomycin F1 to tetracenomycin D3 (C).
|
![]() View larger version (16K): [in a new window] |
FIG. 6. High-performance liquid chromatography analysis of enzyme reaction product. A TSK ODS-120T column (TOSOH) was eluted with gradient of acetonitrile-0.1% acetic acid from 50 to 90% at a flow rate 0.6 ml/min. Elution was monitored at a UV wavelength of 254 nm. (A) Enzyme reaction mixture; (B) enzyme reaction mixture with authentic emodin; (C) emodinanthrone.
|
Expression of mutant AknX. As was reported for related oxygenase enzymes such as TcmH (15) and ActVA6 (9), no apparent prosthetic group was involved in the oxygenation reaction of AknX. In general, the activation of molecular oxygen is required to incorporate oxygen into the substrate molecule (7, 13, 19). Thus, some amino acid residues might have a role in oxygen activation. To identify such key amino acid residues, site-directed mutagenesis was carried out. Of the conserved basic and/or aromatic amino acid residues in AknX, TcmH, and ActVA6, Arg-42, His-49, Trp-67, Arg-74, and His-85 were chosen as target residues. In addition, Cys-52 was included because Shen and Hutchinson commented on the possible involvement of a sulfhydryl group in TcmH monooxygenase (15). Expression plasmids for mutant AknXs were constructed based on PCR mutagenesis as described in Materials and Methods. Mutant AknXs, R42K, H49A, H49Q, C52S, W67F, R74K, and H85A, were expressed with the His6 tag at their C termini in E. coli and purified by Ni2+ affinity column chromatography as performed for AknX His-C expressed by pET hisC-X. The results of SDS-PAGE analysis of mutant AknX expression and purification are shown in Fig. 7. All purified mutant proteins appeared as apparent single bands at 21.5 kDa.
![]() View larger version (67K): [in a new window] |
FIG. 7. SDS-PAGE analysis of mutant AknXs. (A) Cell extracts of control transformant with pET22b and transformants expressing mutant AknXs. (B) Ni2+ affinity purified mutants. Lanes M: molecular mass marker. After electrophoresis, the gel (15% acrylamide) was stained with Coomassie brilliant blue.
|
|
View this table: [in a new window] |
TABLE 1. Kinetic analysis of mutated AknXsa
|
AknX His-N also showed anthrone oxygenase activity and was purified to homogeneity by Ni2+ affinity column and then Mono Q anion-exchange column chromatography as judged by SDS-PAGE (21.5 kDa) and TOF-MS (14,486 Da) analyses. Starting from an 8-liter induction culture of pET hisN-X transformant, 38.9 mg of homogeneous AknX His-N was obtained. The results of the purification are summarized in Table 2.
|
View this table: [in a new window] |
TABLE 2. Purification of recombinant AknX His-Na
|
|
|
|---|
In genetic studies on anthracycline biosynthesis, similar small ORFs were identified in the biosynthetic gene clusters just upstream from the KS gene in S. peucetius (6), Streptomyces sp. strain C5 (20), Streptomyces nogalater (21), and S. galilaeus (4). Their homology with tcmH suggested that the encoded enzyme might catalyze the oxygenation of aklanonic acid anthrone to form aklanonic acid. However, their catalytic activities have not been identified. In this report, we overexpressed AknX protein and identified it as an anthrone oxygenase.
Shen and Hutchinson proposed that the reaction mechanism of TcmH monooxygenase is a radical process including generation of superoxide anion radical and radical enzyme (15). However, the anthrone oxygenase activity of AknX was not affected by superoxide dismutase. They also commented on the possible involvement of a sulfhydryl group for TcmH monooxygenase activity, although Cys residues are not conserved in other streptomycete oxygenases of this type and the C52S mutant of AknX retained its oxygenase activity.
Kendrew et al. suggested that His-52 may have a role as a key amino acid in ActVA6 enzyme activity (9). They proposed that His-52 acts as a general base catalyzing the dehydration of the putative peroxide intermediate. We expressed mutants of AknX His-49, which corresponds to His-52 of ActVA6. AknX H49Q and H49A showed 40 and 445% of the enzyme activities of AknX His-49, respectively. This implies that His-49 is not the essential residue, at least in the AknX enzyme reaction. Kinetic analysis of mutant AknXs suggested that the Trp-67 residue plays a key role in the AknX oxygenation reaction.
In addition to aknX, tcmH, and actVA6, several genes such as dnrG of S. peucetius (6), dauG of Streptomyces sp. strain C5 (20), snoaB of S. nogalater (21), mtmOIII of Streptomyces argillaceus (11), and frnU of Streptomyces roseofulvus, have been reported to be possibly involved in similar oxygenation reactions. The phylogenetic relationship of their gene products is shown in Fig. 8. The possible aklanonic acid anthrone oxygenases AknX, DnrG, DauG, and SnoaB are closely related in one branch and have a distal relationship with other oxygenases: TcmH, ActVA6, MtmOIII, and FrnU. Their amino acid sequence alignment shows that only four amino acid residuesPro-44, Gly-45, Ala-65, and Trp-67in the AknX sequence are fully conserved in these proteins. This also suggested the important role of the Trp-67 residue in the catalytic function of AknX.
![]() View larger version (48K): [in a new window] |
FIG. 8. Phylogenetic tree and amino acid sequence alignment of AknX and related streptomycete oxygenases. (A) The sequences were aligned and homology scores were obtained using the program CLUSTAL W. Highly conserved amino acid residues are in black boxes. (B) The phylogenetic tree was developed with the same program using the neighbor-joining method and drawn with TREE VIEW. The indicated scale represents 0.1 amino acid substitution per site.
|
-
complexation with Trp-67 in a fixed orientation. Then, hydroperoxyanthorne is formed by dioxygen addition and subsequently dehydrated to form anthraquinone (Fig. 9).
![]() View larger version (10K): [in a new window] |
FIG. 9. Proposed mechanism for the AknX-catalyzed oxygenase reaction.
|
This work was in part supported by a grant-in-aid for scientific research (C) (08672411 to I.F.) from The Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan.
Present address: Perinatal Research Laboratories, Department of Obstetrics and Gynecology, University of WisconsinMadison, Madison, WI 53715. ![]()
Present address: International Traditional Medicine Research Center, Toyama International Health Complex, Toyama 939-8224, Japan. ![]()
|
|
|---|
B. Bioorg. Med. Chem. Lett. 3:1089-1094.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»